BREAST CANCER: Capecitabine cuts risk of breast cancer recurrence BREAST CANCER: Lapatinib helps control metastatic breast cancerBiologic agent added to aromatase inhibitor Depression front-runner New-generation antidepressant sertraline has best balance between benefits, acceptability and cost Genetic clues may aid preterm prevention BREAST CANCER: Toremifene matches tamoxifen in early stage breast cancer outcomes Antiplatelet response is in the genes But genetic testing isn't ready yet, MDs say Canada leads in hypertension treatment U of Calgary study shows drop in deaths CA and Healthscreen form partnership Chronic disease programs for doctors New guide for palliative caregivers A revised source of information and a practical tool for helping people live through the suffering often experienced at end of life. Olmetec: new angiotensin II blocker coming soon Schering-Plough will soon be launching Olmetec and Olmetec Plus for the treatment of mild to moderate hypertension. First Previous 2257 2258 2259 2260 2261 Next Last
